ClinicalTrials.gg
CompletedNCT03291717BCGPUpdated Sep 16, 2020

Bridging Community Gaps Photovoice

An interventional study of Bridging Community Gaps Photovoice (BCGP) in Mental Illness and Social Isolation, sponsored by Boston University Charles River Campus. Completed at 4 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-09-16.

Sponsored by Boston University Charles River Campus · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
197
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to test a peer-led intervention intended to promote the community living and participation of individuals with psychiatric disabilities entitled "Bridging Community Gaps Photovoice" (BCGP). The intervention targets increasing community involvement of individuals with psychiatric disabilities through reduction in self-stigma and perceived stigma, enhancing opportunities for community participation, and support to achieve community participation goals.

Read the detailed description

The BCGP intervention is 6 months long and the investigators expect that participants will experience lower self and perceived stigma, increased community participation and sense of belonging, and improved psychosocial functioning and personal growth after the intervention. The intervention is comprised of a 12-week class that meets once a week for two hours, followed by three booster sessions - one per month in the three months following the class, and up to 24 sessions of individual support as needed throughout the 6 months provided on a weekly basis either in person or by phone. The purpose of the individual support is to reinforce the class activities and to ensure the participants meets their community participation goal. The proposed study is a randomized trial which will be conducted at Boston University Center for Psychiatric Rehabilitation (BUCPR) in Massachusetts, the Mental Health Center of Denver (MHCD) in Colorado, and the Greater Bridgeport Mental Health Center (GBMHC) in Connecticut.

02

Conditions studied

  • Mental Illness
  • Social Isolation

Keywords

  • Mental Illness
  • Community Participation
  • Stigma
  • Photovoice
03

In context

Mental Disorders

1,740 studies on the registry are indexed under Mental Disorders; 348 are open to participants now.

This study's enrollment of 197 is above the median of 100 across 1,301 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Boston University Charles River Campus is the lead sponsor of 159 studies on the registry; 33 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 9 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. are 18 or older.
  2. are recipients of services at research sites due to having a diagnosis of mental illness, including dual diagnosis (dual diagnosis refers to co-occurring mental illness and alcohol/ substance use disorder).
  3. are interested in enhancing their community participation.
  4. are not currently receiving individual peer support services.
  5. are able to read and write in English.

Exclusion criteria

Exclusion Criteria:

1)Inability to give full and knowing consent.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
197 participants (actual)

Study arms

  • Experimental
    Bridging Community Gaps Photovoice (BCGP)

    The BCGP program is a 6-month photovoice-based intervention to help individuals with psychiatric disabilities enhance their community participation.

    Behavioral: Bridging Community Gaps Photovoice (BCGP)

  • No intervention
    Services as Usual

    Individuals in this group continue with their regular mental health services with no additional intervention.

Interventions

  • BehavioralBridging Community Gaps Photovoice (BCGP)

    Participants assigned to this group will be part of the 6-month long BCGP intervention, which involves a 12- week class that meets weekly, followed by three booster sessions - one per month in the three months following the class, and up to 24 sessions of individual support as needed throughout the 6 months provided on a weekly basis either in person or by phone. The BCGP classes follow a manualized curriculum with sessions that combine didactic information, Photovoice exercises, and group discussions to empower participants in pursuing community participation goals, all refined with input from individuals with a lived experience.

06

What researchers measure

Primary outcomes

  1. UCLA Loneliness Scale

    is a 20-item 4-point Likert-type scale, widely used measure of loneliness and social isolation. Cronbach's alpha coefficients ranging from .89 to .94.

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

  2. Multi-Dimensional Assessment of Community Participation

    Consists of a set of objective and subjective measures of community belonging, inclusion and participation.

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

Secondary outcomes

  1. Internalized Stigma of Mental Illness Scale

    29-item, 4-point scale from (strongly disagree to strongly agree) assesses behaviors, thoughts and feelings that are self-stigmatizing including alienation, stereotype endorsement, social withdrawal, stigma resistance.

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

  2. The Stigma Scale

    28 item, 5 point scale (strongly disagree to strongly agree) measuring experienced and anticipated stigma.

    Time frame: Change from Baseline to 3 months, 3 months to 6 months, 6 months to 9 months, 9 months to 12 months

  3. Approaches to Coping with Anti-Stigma

    27-item instrument with a 4 point scale (strongly disagree to strongly agree) measuring strategies to cope with stigma: secrecy, withdrawal, educating, challenging, and distancing.

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

  4. Personal Growth and Recovery Scale

    25-item, 4 point scale (strongly disagree to strongly agree) of items measuring psychosocial functioning and recovery.

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

  5. Community Goal Achievement Scale

    adapted from Goal Attainment Scale, provides a structured approach to determining goal achievement regardless of the type or uniqueness of goal .

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

  6. Behavior and Symptom Identification Scale (BASIS - R)

    A 24-item scale that measures: mood disturbances, anxiety, interpersonal and role functioning, daily living skills, psychotic symptoms, impulsivity and substance use

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

07

Study locations

4 sites
  • Mental Health Center of Denver
    Denver, Colorado 80204, United States
  • Greater Bridgeport Mental Health Center
    Bridgeport, Connecticut 06610, United States
  • Boston University, Center for Psychiatric Rehabilitation
    Boston, Massachusetts 02215, United States
  • Horizon House- Riverside Community Care
    Wakefield, Massachusetts 01880, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2017 to primary completion in Sep 2020, 36 months.

Of 666 non-industry interventional studies with no phase under Mental Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 45. This study's 36 months is above that.

Counting every sponsor, half of 680 studies reached it within 29 months; a quarter within 13 and three quarters within 45.

Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 19, 2017
First posted
Sep 25, 2017
StartActual
Sep 5, 2017
Primary completionActual
Sep 11, 2020
CompletionActual
Sep 11, 2020
Last update
Sep 16, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03291717
Collaborators
Mental Health Center of Denver, Connecticut State, Department of Mental Health and Addiction Services, Riverside Community Care
Responsible party
Erna Sally Rogers (Research Professor, Boston University Charles River Campus) — Principal investigator
First posted
Sep 25, 2017
Start date
Sep 5, 2017
Primary completion
Sep 11, 2020
Completion
Sep 11, 2020
Last update
Sep 16, 2020

Study contacts

Erna S Rogers, PhD
principal investigator · Boston University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion